Get informed when a big investor buys or sells
+ FollowOvervalued by 95.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $852,442.00 |
|---|---|
| Enterprise Value | $831,680.00 |
| Earnings per Share | $0 |
| Beta | 6.22 |
| Outstanding Shares | 1,549,331 |
| P/E Ratio | -0.2 |
|---|---|
| PEG | 0.09 |
| Price to Sales | - |
| Price to Book Ratio | -0.55 |
| Enterprise Value to Revenue | 9.69 |
| Enterprise Value to EBIT | -0.09 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Zhengduozhe Technology Inc., operating as DAKOTA Life Sciences, is a biopharmaceutical enterprise dedicated to the acquisition, development, and commercialization of therapeutic agents. These pharmaceuticals are specifically engineered t...